While the Public is Still on the Fence, it Looks Like Washginton is Sold on the Pfizer Vaccine

With countless polls across the country from a variety of sources, including this one from the Associated Press, reporting that roughly half of all Americans are still very much on the fence about getting the COVID-19 vaccine, the U.S. Government continues to march forward. Today, it was announced that Pfizer (PFE) and its drugmaking partner BioNTech

Read More ›

Market Overview